<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02676726</url>
  </required_header>
  <id_info>
    <org_study_id>P14/1817</org_study_id>
    <nct_id>NCT02676726</nct_id>
  </id_info>
  <brief_title>STELLA 2 Trial: Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Staging of Endometrial/Ovarian Cancer</brief_title>
  <acronym>STELLA-2</acronym>
  <official_title>STELLA 2 Trial: Staging of Endometrial and Ovarian Cancer Comparing the Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Lymphadenectomy of Aortic Nodes, Evaluating Complications</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitari Vall d'Hebron Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>European Regional Development Fund</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Universitari Vall d'Hebron Research Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether or not there are more complications in the
      extraperitoneal compared with the transperitoneal approach for laparoscopic aortic
      lymphadenectomy for the surgical staging of endometrial or ovarian cancer
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2014</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Surgical complications</measure>
    <time_frame>intraoperatively, within 30 days after surgery, and past 30 days after surgery up to 3 months after surgery</time_frame>
    <description>Composite outcome defined by including at least one of the following:
Total estimated blood loss &gt; 500 mL during surgery
Blood transfusion
Intraoperative complication classified as Dindo grade III or worse, related to the aortic lymphadenectomy
Early postoperative complication (within 30 days after surgery) classified as Dindo grade III or worse, related to the aortic lymphadenectomy
Late postoperative complication (past 30 days after surgery) classified as Dindo grade III or worse, related to the aortic lymphadenectomy
Conversion to laparotomy during the aortic lymphadenectomy
Inability to complete the aortic lymphadenectomy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of lymph nodes</measure>
    <time_frame>Postoperatively (within 1 week), at the moment of histopathologic examination</time_frame>
    <description>The number of lymph nodes (absolute number) is specified by the pathologist on histopathological analysis of the sample sent by the surgeon after surgical staging is realized (laparoscopic aortic lymphadenectomy). This variable is subdivided into: supra-mesenteric and infra-mesenteric.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative time</measure>
    <time_frame>At the time of the surgery</time_frame>
    <description>Total duration of surgery (from initial skin incision to end of skin suture), and total aortic lymphadenectomy time (time spent since the beginning of aortic lymphadenectomy to its completion). Metric: minutes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital stay</measure>
    <time_frame>Measured the day the patient is discharged (up to 100 days)</time_frame>
    <description>The number of days that patients stay in the hospital after surgery, measured in days from the day of the surgery to the day the patient is discharged from the hospital.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall survival</measure>
    <time_frame>up to 3 years after surgery</time_frame>
    <description>Number of patients alive after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disease-free survival</measure>
    <time_frame>up to 3 years after surgery</time_frame>
    <description>Period of time in which there is no appearance of the symptoms or effects of the disease.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">208</enrollment>
  <condition>Endometrial Neoplasms</condition>
  <condition>Ovarian Neoplasms</condition>
  <arm_group>
    <arm_group_label>Extraperitoneal</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients who where randomized to extraperitoneal laparoscopic aortic lymphadenectomy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Transperitoneal</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients who where randomized to transperitoneal laparoscopic aortic lymphadenectomy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Extraperitoneal Laparoscopic aortic lymphadenectomy</intervention_name>
    <description>Aortic/para-aortic lymph nodes dissection and retrieval by extraperitoneal laparoscopy; the intervention may be completed by robotic-assisted or traditional laparoscopy.</description>
    <arm_group_label>Extraperitoneal</arm_group_label>
    <other_name>Extraperitoneal laparoscopic para-aortic lymphadenectomy</other_name>
    <other_name>Retroperitoneal laparoscopic lumbo-aortic lymphadenectomy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transperitoneal Laparoscopic aortic lymphadenectomy</intervention_name>
    <description>Aortic/para-aortic lymph nodes dissection and retrieval by transperitoneal laparoscopy; the intervention may be completed by robotic-assisted or traditional laparoscopy.</description>
    <arm_group_label>Transperitoneal</arm_group_label>
    <other_name>Transperitoneal laparoscopic para-aortic lymphadenectomy</other_name>
    <other_name>Transperitoneal laparoscopic lumbo-aortic lymphadenectomy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of endometrial cancer confirmed by histopathological analysis (endometrial
             biopsy) requiring surgical staging according to FIGO (the International Federation of
             Gynecology and Obstetrics) recommendations

          -  Diagnosis of ovarian cancer confirmed by histopathological analysis after an initial
             cystectomy or oophorectomy without suspicion of neoplasia thus requiring additional
             surgical staging according to FIGO recommendations

        Exclusion Criteria:

          -  Diagnosis of advanced endometrial cancer based on findings on imaging techniques (CT,
             MRI and/or PET)

          -  Diagnosis of advanced endometrial or ovarian cancer based on intraoperative findings
             (e.g. peritoneal carcinomatosis at initial laparoscopy)

          -  Patients who underwent previous aortic lymphadenectomy

          -  Patients who received previous pelvic and/or aortic radiotherapy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antonio Gil Moreno, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Berta Diaz Feijoo, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alejandro Correa Paris, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona</affiliation>
  </overall_official>
  <overall_official>
    <last_name>M. Assumpció Pérez-Benavente, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Silvia Franco Camps, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jose Luis Sánchez Iglesias, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Silvia Cabrera Díaz, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Oriol Puig Puig, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Javier De La Torre, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Berta Díaz Feijoo, MD, PhD</last_name>
    <phone>0034934893066</phone>
    <email>bdiaz@vhebron.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alejandro Correa Paris, MD</last_name>
    <email>correa.alejandro@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Berta Diaz Feijoo, MD, PhD</last_name>
      <phone>0034934893066</phone>
      <email>bdiaz@vhebron.net</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Vasilev SA, McGonigle KF. Extraperitoneal laparoscopic para-aortic lymph node dissection. Gynecol Oncol. 1996 Jun;61(3):315-20.</citation>
    <PMID>8641608</PMID>
  </reference>
  <reference>
    <citation>Dowdy SC, Aletti G, Cliby WA, Podratz KC, Mariani A. Extra-peritoneal laparoscopic para-aortic lymphadenectomy--a prospective cohort study of 293 patients with endometrial cancer. Gynecol Oncol. 2008 Dec;111(3):418-24. doi: 10.1016/j.ygyno.2008.08.021. Epub 2008 Oct 2.</citation>
    <PMID>18835020</PMID>
  </reference>
  <reference>
    <citation>Gil-Moreno A, Maffuz A, Díaz-Feijoo B, Puig O, Martínez-Palones JM, Pérez A, García A, Xercavins J. Modified approach for extraperitoneal laparoscopic staging for locally advanced cervical cancer. J Exp Clin Cancer Res. 2007 Dec;26(4):451-8.</citation>
    <PMID>18365538</PMID>
  </reference>
  <reference>
    <citation>Gil-Moreno A, Díaz-Feijoo B, Morchón S, Xercavins J. Analysis of survival after laparoscopic-assisted vaginal hysterectomy compared with the conventional abdominal approach for early-stage endometrial carcinoma: a review of the literature. J Minim Invasive Gynecol. 2006 Jan-Feb;13(1):26-35.</citation>
    <PMID>16431320</PMID>
  </reference>
  <reference>
    <citation>Gil-Moreno A, Díaz-Feijoo B, Pérez-Benavente A, del Campo JM, Xercavins J, Martínez-Palones JM. Impact of extraperitoneal lymphadenectomy on treatment and survival in patients with locally advanced cervical cancer. Gynecol Oncol. 2008 Sep;110(3 Suppl 2):S33-5. doi: 10.1016/j.ygyno.2008.03.024. Epub 2008 Jun 5.</citation>
    <PMID>18538379</PMID>
  </reference>
  <reference>
    <citation>Gil-Moreno A, Franco-Camps S, Díaz-Feijoo B, Pérez-Benavente A, Martínez-Palones JM, Del Campo JM, Parera M, Verges R, Castellví J, Xercavins J. Usefulness of extraperitoneal laparoscopic paraaortic lymphadenectomy for lymph node recurrence in gynecologic malignancy. Acta Obstet Gynecol Scand. 2008;87(7):723-30. doi: 10.1080/00016340802136343.</citation>
    <PMID>18607826</PMID>
  </reference>
  <reference>
    <citation>Pakish J, Soliman PT, Frumovitz M, Westin SN, Schmeler KM, Reis RD, Munsell MF, Ramirez PT. A comparison of extraperitoneal versus transperitoneal laparoscopic or robotic para-aortic lymphadenectomy for staging of endometrial carcinoma. Gynecol Oncol. 2014 Feb;132(2):366-71. doi: 10.1016/j.ygyno.2013.12.019. Epub 2013 Dec 20.</citation>
    <PMID>24361579</PMID>
  </reference>
  <reference>
    <citation>Dowdy SC, Mariani A. Lymphadenectomy in endometrial cancer: when, not if. Lancet. 2010 Apr 3;375(9721):1138-40. doi: 10.1016/S0140-6736(09)62068-7. Epub 2010 Feb 24.</citation>
    <PMID>20188409</PMID>
  </reference>
  <reference>
    <citation>Mariani A, Dowdy SC, Cliby WA, Gostout BS, Jones MB, Wilson TO, Podratz KC. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol. 2008 Apr;109(1):11-8. doi: 10.1016/j.ygyno.2008.01.023. Epub 2008 Mar 4.</citation>
    <PMID>18304622</PMID>
  </reference>
  <reference>
    <citation>Gil-Moreno A, Franco-Camps S, Cabrera S, Pérez-Benavente A, Martínez-Gómez X, Garcia A, Xercavins J. Pretherapeutic extraperitoneal laparoscopic staging of bulky or locally advanced cervical cancer. Ann Surg Oncol. 2011 Feb;18(2):482-9. doi: 10.1245/s10434-010-1320-9. Epub 2010 Sep 14.</citation>
    <PMID>20839058</PMID>
  </reference>
  <reference>
    <citation>Díaz-Feijoo B, Gil-Ibáñez B, Pérez-Benavente A, Martínez-Gómez X, Colás E, Sánchez-Iglesias JL, Cabrera-Díaz S, Puig-Puig O, Magrina JF, Gil-Moreno A. Comparison of robotic-assisted vs conventional laparoscopy for extraperitoneal paraaortic lymphadenectomy. Gynecol Oncol. 2014 Jan;132(1):98-101. doi: 10.1016/j.ygyno.2013.11.004. Epub 2013 Nov 11.</citation>
    <PMID>24231134</PMID>
  </reference>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 14, 2015</study_first_submitted>
  <study_first_submitted_qc>February 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 8, 2016</study_first_posted>
  <last_update_submitted>February 3, 2016</last_update_submitted>
  <last_update_submitted_qc>February 3, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 8, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>extraperitoneal</keyword>
  <keyword>transperitoneal</keyword>
  <keyword>laparoscopic aortic lymphadenectomy</keyword>
  <keyword>endometrial cancer</keyword>
  <keyword>ovarian cancer</keyword>
  <keyword>surgical staging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Ovarian Neoplasms</mesh_term>
    <mesh_term>Endometrial Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

